Immuno-Precision X-platform
インプレックス株式会社株式会社ImmprexAlias
Ticker
—
Listed market
—
Country
Employees (non-consolidated)
6
Related companies
0
§01
Basic information
- Head office
- 7-15-9 Jōyama-dai, Kizugawa City, Kyoto Prefecture, Japan
- Chief executive
- Hiroshi Hashioka
- Capital
- 21,500,000
- Employees (non-consolidated)
- 6 people
- Employees (consolidated)
- Start date
- 2022-11-28
- End date
§02
Websites
§03
Business
Research and development, manufacturing, and sales of cancer immunotherapy / cancer vaccines, stem cell therapies, etc.Operation and nationwide expansion of the Immuno Precision Medicine Clinic 'Aladdin Clinic'.Research, development, and operation of DC amplification technology.Immunotherapy for mild cognitive impairment, depression, and anti-aging.Development and operation of a shared electronic medical record system.Operation of a comprehensive immunotherapy information website.Operation of the Advanced Cell Culture Technician Training Institute.Import, sale, and maintenance of CPC (cell culture facilities, equipment, etc.).Operation of the Immunotherapy Service Membership System 'Early Detection and Complete Cure Program'.All ancillary activities related to the above.
§04
Related companies
—
§05
Network
Drag to move · click to open
§07
News
There is no news.
§09
Sources & updates
DOMAINOwn domain:Yes
UPDATED2026-10-27 01:03 · Model: gpt-oss-20b(16)